Benjamin G. Wu

Intensive Care Medicine

462 1st Ave
New York, NY 10016

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF.

Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF.

Journal: Science translational medicine

Published: June 03, 2026

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Journal: Clinics in chest medicine

Published: May 27, 2026

Aging Associated Transcriptomic Signatures in Tumor and Tumor Adjacent Lung Tissues Associated with Recurrence Following Resection of Stage I Lung Adenocarcinoma.

Aging Associated Transcriptomic Signatures in Tumor and Tumor Adjacent Lung Tissues Associated with Recurrence Following Resection of Stage I Lung Adenocarcinoma.

Journal: Research square

Published: March 16, 2026

Rethinking pneumonia in terms of the lung microbiome.

Rethinking pneumonia in terms of the lung microbiome.

Journal: Current opinion in pulmonary medicine

Published: February 03, 2026

Lower airway dysbiosis in nontuberculous mycobacteria-positive bronchiectasis is associated with neutrophil extracellular trap-predominant severe phenotypes.

Lower airway dysbiosis in nontuberculous mycobacteria-positive bronchiectasis is associated with neutrophil extracellular trap-predominant severe phenotypes.

Journal: American journal of respiratory and critical care medicine

Published: August 01, 2025

Microbial contribution to metabolic niche formation varies across the respiratory tract.

Microbial contribution to metabolic niche formation varies across the respiratory tract.

Journal: Cell host & microbe

Published: January 21, 2025

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis.

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2024

The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.

The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.

Journal: ERJ open research

Published: August 17, 2024

Metagenomic Sequencing for Personalized Treatment in Pneumonia: Does Better Detection Lead to Better Outcomes?

Metagenomic Sequencing for Personalized Treatment in Pneumonia: Does Better Detection Lead to Better Outcomes?

Journal: Chest

Published: August 07, 2024

Lung allograft dysbiosis associates with immune response and primary graft dysfunction.

Lung allograft dysbiosis associates with immune response and primary graft dysfunction.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: June 11, 2024

Bad company? The pericardium microbiome in people investigated for tuberculous pericarditis in an HIV-prevalent setting.

Bad company? The pericardium microbiome in people investigated for tuberculous pericarditis in an HIV-prevalent setting.

Journal: Microbes and infection

Published: May 21, 2024

Bad company? The pericardium microbiome in people investigated for tuberculosis pericarditis in an HIV-prevalent setting.

Bad company? The pericardium microbiome in people investigated for tuberculosis pericarditis in an HIV-prevalent setting.

Journal: medRxiv : the preprint server for health sciences

Published: May 07, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026